To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis | MicrobiomeTrials← Back to trialsNCT07629583
To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-07-31Est. Completion: 2030-03-29
Enrollment target: 46 participants Other microbiome trials you might be interested in
Vaccine ReactionZosterSystemic Lupus Erythematosus
The goal of this observational study is to compare the vaccine response to the 2 doses of the adjuvanted herpes zoster s…
Seoul, South KoreaEst. completion Oct 1, 2030
Refractory/Relapsed Systemic Lupus ErythematosusRefractory / Relapsed / Progressive Systemic SclerosisRefractory / Relapsing / Progressive Inflammatory MyopathyRefractory / Relapsed Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated VasculitisRefractory / Relapsed Connective Tissue Disease-Associated Thrombocytopenia
This study is a single-arm, intervention, dose-escalation clinical trial to evaluate the safety of allogeneic CD19/BCMA-…
Multiple LocationsEst. completion Dec 31, 2028
Systemic Lupus ErythematosusRheumatoid Arthritis
Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity.
Rhe…
Los Angeles, United StatesEst. completion Jan 2029